Deep Ophthalmic Limited 15277231 false 2023-12-01 2024-11-30 2024-11-30 The principal activity of the company is Repair not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true 15277231 2023-12-01 2024-11-30 15277231 2024-11-30 15277231 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 15277231 bus:Micro-entities 2023-12-01 2024-11-30 15277231 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 15277231 bus:FilletedAccounts 2023-12-01 2024-11-30 15277231 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 15277231 bus:RegisteredOffice 2023-12-01 2024-11-30 15277231 bus:Director1 2023-12-01 2024-11-30 15277231 bus:Director2 2023-12-01 2024-11-30 15277231 bus:Director3 2023-12-01 2024-11-30 15277231 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 15277231 countries:AllCountries 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Registration number: 15277231

Deep Ophthalmic Limited
Unaudited Filleted Financial Statements
for the Year Ended 30 November 2024

Deep Ophthalmic Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 2

Deep Ophthalmic Limited

Company Information

Directors | Mrs Gursharon Kaur Dayhia Mr Deep Kanwal Singh Mr Ryan Singh Dayhia

Registered office | Office 20, West Midlands House Gipsy Lane Willenhall West Midlands WV13 2HA

Accountants | A Singh Accountancy Office 20, West Midlands House Gipsy Lane Willenhall West Midlands WV13 2HA

Deep Ophthalmic Limited

(Registration number: 15277231)
Balance Sheet as at 30 November 2024

| 2024 £
Fixed assets | 12,280
Current assets | 7,827
Creditors: Amounts falling due within one year | (19,711)
Net current liabilities | (11,884)
| 396
Capital and reserves | 396

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Office 20, West Midlands House
Gipsy Lane
Willenhall
West Midlands
WV13 2HA
United Kingdom

These financial statements were authorised for issue by the Board on 16 October 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3.

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Deep Ophthalmic Limited

(Registration number: 15277231)
Balance Sheet as at 30 November 2024

Approved and authorised by the Board on 16 October 2025 and signed on its behalf by:

......................................... Mrs Gursharon Kaur Dayhia Director
......................................... Mr Deep Kanwal Singh Director
......................................... Mr Ryan Singh Dayhia Director